Key result
AVR in patients aged 85-91 yields ~85% one-year survival with improved symptoms and QoL.
Why the study?
Does aortic valve replacement improve survival and quality of life in patients older than 85 years with symptomatic aortic stenosis?
Cohort (n=21)
Does aortic valve replacement improve survival and quality of life in patients older than 85 years with symptomatic aortic stenosis?
Answers are grounded in this paper and cite their sources.
Aortic valve replacement in highly symptomatic patients over 85 years old is feasible and associated with improved survival and quality of life, though concomitant CABG increases early mortality risk.
PURPOSE: The aim of this study was to investigate the outcome of aortic valve replacement (AVR) and the effect on quality of life in patients aged over 85 who had symptomatic aortic stenosis. METHODS: We performed a retrospective analysis of 21 patients, aged 85-91 years (mean age 86.5), who underwent AVR, 10 of whom underwent concomitant coronary artery bypass grafting (CABG) between 1989 and 1995. All patients were categorized as New York Heart Association (NYHA) functional class III and IV. A questionnaire was used to evaluate heart symptoms and quality of life among the 13 patients who were alive at follow-up (9-83 months). RESULTS: Eighteen patients were categorized as NYHA functional class I and II for 1 year (9 months for one patient) after AVR. Three patients, all undergoing concomitant CABG, died early. The overall 1-, 2- and 3-year actuarial survival rate was 85%, 64% and 53% (among the patients undergoing only AVR the figures were 100%, 100% and 85%). Follow-up questionnaire results showed an improvement in the patients' symptoms of heart disease, dyspnea (P = 0.017) and angina (P = 0.03). An improvement in the patients' physical functioning (P = 0.025), satisfaction with physical ability (P = 0.005), sleep (P = 0.025), health status (P = 0.025) and perception of general health (P = 0.005) was also observed. CONCLUSIONS: Our results show that AVR can be performed on patients > or = 85 years of age or older, with an improvement in heart symptoms and quality of life.
No takes yet. Share an insight, caveat, or question.
Levin et al. (1998) conducted a cohort in symptomatic aortic stenosis (n=21). Aortic valve replacement was evaluated on 1-year actuarial survival rate. Aortic valve replacement in patients aged 85-91 years yielded 1-, 2-, and 3-year survival rates of 85%, 64%, and 53%, respectively, with significant improvements in symptoms and quality of life.
Synapse has enriched 10 related papers. Consider them for comparative context: